FcR Therapeutics
Pre-clinicalWe believe that our proprietary drug leads can target Fc receptors to provide a major therapeutic perspective for patients suffering from autoimmune diseases.
Founded
2019
Focus
BiologicsNanotechnology
About
We believe that our proprietary drug leads can target Fc receptors to provide a major therapeutic perspective for patients suffering from autoimmune diseases.
Company Info
TypePrivate
Founded2019
LocationBarcelona, Spain
StagePre-clinical
Contact
SIMILAR COMPANIES
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile